Learn More
Medchemexpress LLC Butanedioic acid, 2-hydroxy-, (2S)-, compd. with (3S)-1-azabicyclo[2.2.2]oct-3-yl N-[1-[2-(4-fluorophenyl)-4-thiazolyl]-1-methylethyl]carbamate (1:1) | 1629063-78-0 | 98.65% | 523.57 | 2 MG

Supplier: Medchemexpress LLC HY16743A2MG
Ibiglustat (L-Malic acid) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. It can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease. It can prevent additional GL-3 accumulation and could ameliorate the abundant levels of sphingolipid in FD cardiomyocytes.
- Orally active
- Brain-penetrant
- Glucosylceramide synthase (GCS) inhibitor
- Soluble in DMSO (≥ 100 mg/mL, 191.00 mM)
- Can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.